REQELJA Trademark

Trademark Overview


On Monday, February 7, 2022, a trademark application was filed for REQELJA with the United States Patent and Trademark Office. The USPTO has given the REQELJA trademark a serial number of 97255833. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, August 20, 2024. This trademark is owned by Epygenix Therapeutics, Inc.. The REQELJA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medical preparations and substances for the treatment of epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, and neurodegenerative diseases; pharmaceutical and medical preparations and substances for the treatment of pediatric epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases; medicinal infusions for the treatment of epilepsy, epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases
reqelja

General Information


Serial Number97255833
Word MarkREQELJA
Filing DateMonday, February 7, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements


Goods and ServicesPharmaceutical and medical preparations and substances for the treatment of epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, and neurodegenerative diseases; pharmaceutical and medical preparations and substances for the treatment of pediatric epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases; medicinal infusions for the treatment of epilepsy, epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpygenix Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462

Party NameEpygenix Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParamus, NJ 07652

Trademark Events


Event DateEvent Description
Thursday, February 10, 2022NEW APPLICATION ENTERED
Friday, February 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 18, 2022ASSIGNED TO EXAMINER
Tuesday, November 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 17, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2023SOU EXTENSION 1 FILED
Thursday, August 17, 2023SOU EXTENSION 1 GRANTED
Tuesday, July 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 29, 2024SOU EXTENSION 2 FILED
Monday, January 29, 2024SOU EXTENSION 2 GRANTED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 20, 2024SOU EXTENSION 3 FILED